Publications

Latest publication 01/30/2009

Amiloride enhances the anticonvulsant action of various antiepileptic drugs in t

Accumulating evidence indicates that amiloride (a potassium-sparing diuretic) exerts the anticonvulsant action in various in vivo and in vitro...

Array
(
    [id_prestablog_news] => 200
    [id_shop] => 1
    [date] => 2009-01-30 00:00:00
    [date_modification] => 2024-02-09 14:15:11
    [langues] => ["1","2"]
    [actif] => 1
    [slide] => 0
    [url_redirect] => 
    [average_rating] => 
    [number_rating] => 
    [author_id] => 1
    [featured] => 0
    [ishero] => 0
    [prim_key] => 397
    [id_lang] => 1
    [title] => Amiloride enhances the anticonvulsant action of various antiepileptic drugs in t
    [paragraph] => Amiloride enhances the anticonvulsant action of various antiepileptic drugs in the mouse maximal electroshock seizure model.
    [content] => 
Authors
J. J. Luszczki, K. M. Sawicka, J. Kozinska, M. Dudra-Jastrzebska, S. J. Czuczwar.

 Lab
Medical University, Department of Pathophysiology, and Institute of Agricultural Medicine, Department of Physiopathology, Lublin, Poland.
Journal
Journal of Neural Transmission
Abstract
Accumulating evidence indicates that amiloride (a potassium-sparing diuretic) exerts the anticonvulsant action in various in vivo and in vitro experiments. Therefore, the objective of this study was to assess the influence of amiloride on the protective action of numerous conventional and second-generation antiepileptic drugs [AEDs: carbamazepine (CBZ), lamotrigine (LTG), oxcarbazepine (OXC), phenobarbital (PB), topiramate (TPM), and valproate (VPA)] against maximal electroshock (MES)-induced seizures in mice. Results indicate that amiloride [up to 100 mg/kg, intraperitoneally (i.p.), at 30, 60, and 120 min before the test] neither altered the threshold for electroconvulsions, nor protected the animals against MES-induced seizures in mice. Moreover, amiloride (75 and 100 mg/kg, i.p., 120 min prior to the test) significantly enhanced the anticonvulsant effects of all studied AEDs, except for LTG, by reducing their ED50 values in the MES test. In contrast, amiloride at 50 mg/kg (i.p.) had no significant effect on the antielectroshock action of the tested AEDs in mice. Estimation of total brain AED concentrations revealed that amiloride (75 mg/kg) significantly increased total brain concentrations of CBZ, OXC, and PB, but not those of LTG, TPM, and VPA in mice. In conclusion, one can ascertain that the potentiation of the antiseizure action of TPM and VPA by amiloride in the MES test and lack of any pharmacokinetic interactions between drugs, make the combinations of amiloride with TPM and VPA of pivotal importance for epileptic patients.
BIOSEB Instruments Used
Grip strength test (BIO-GS3)

Keywords/Topics
Epilepsy; Central Nervous System (CNS)
    [meta_description] => 
    [meta_keywords] => http://www.springerlink.com/content/uh0732h61837pn57/
    [meta_title] => 
    [link_rewrite] => amiloride-enhances-the-anticonvulsant-action-of-various-antiepileptic-drugs-in-the-mouse-maximal-electroshock-seizure-model-
    [actif_langue] => 1
    [read] => 1214
    [count_comments] => 0
    [id] => 200
    [categories] => Array
        (
            [11] => Array
                (
                    [id_prestablog_categorie] => 11
                    [title] => Central Nervous System (CNS)
                    [link_rewrite] => Central-Nervous-System-(CNS)
                )

            [41] => Array
                (
                    [id_prestablog_categorie] => 41
                    [title] => Epilepsy
                    [link_rewrite] => Epilepsy
                )

            [2] => Array
                (
                    [id_prestablog_categorie] => 2
                    [title] => Publications
                    [link_rewrite] => publications
                )

        )

    [authors] => 
    [paragraph_crop] => Amiloride enhances the anticonvulsant action of various antiepileptic drugs in the mouse [...]
    [link_for_unique] => 1
    [products_liaison] => Array
        (
            [48] => Array
                (
                    [name] => Grip strength test
                    [description_short] => 
An easy way to objectively quantify the muscular strength of mice and rats, and to assess the effect of drugs, toxins, muscular (i.e. myopathy) and neurodegenerative diseases on muscular degeneration. It is widely used in conjunction with the ROTAROD motor coordination test: a normally coordinated rodent will show a decreased latency to fall off the rotating rod if its muscular strength is low. The Grip Strength Test is a must for your research on activity, motor control & coordination, and is particularly well suited for studies on Parkinson's & Huntington's disease.
New features GS4 - 2023: Color display with permanent backlight screen for easier reading, reset by footswitch, Improved battery time, Larger data memory of 500 values, Animal counter, USB port (charging/data transfer)

                    [thumb] => 
                    [img_empty] => /var/www/vhosts/de3310.ispfr.net/bioseb2024/modules/prestablog/views/img/product_link_white.jpg
                    [image_presente] => 1
                    [link] => https://bioseb.com/en/activity-motor-control-coordination/48-grip-strength-test.html
                )

        )

)
1